Wednesday, 20 May 2026
  
Login

Australia's most trusted
source of pharma news

Wednesday, 20 May 2026
Ascott 2
Ascott 2
Drug pulled after less than 3 years

This company has officially pulled its drug from the Australian market as of today after just 34 months, choosing not to pursue full registration for commercial reasons.

Obesity drugs now gold standard
Heart Foundation includes weight loss drugs in its new guidance for treating obesity and reducing the risk of heart attack or stroke
TODAY
Pharma spend on HCPs doubles
The 10 companies spending the most on HCPs forked out a total of $11.5M in just seven months, with six spending $1M-plus each
TODAY
Medscape
Medscape
Which Drs really distrust pharma?
Four out of five Millennial doctors have a negative view of pharma, and they're about to become the biggest cohort of clinicians
19 May
World's Most Innovative Pharma is...
Company named the world's most innovative pharma for developing a drug which could herald the end of this disease
19 May
Inside Aussie Med Affairs salaries
This survey takes a deep dive into the pay packets of Medical Affairs staffers across the world, including Australia
18 May
Aussie GM steps up to regional role
Less than 18 months after taking the ANZ General Manager role, a major promotion for this high-flyer with hunt on for a successor
18 May
ADG PRIME
ADG PRIME
Latest Jobs
Drugs battle for US$2.7B market
The pending launch of five new drugs will disrupt this growing market which is currently dominated by a single treatment
TODAY
Big demand for hot ticket event
A free virtual event being held today has attracted 550-plus registrants and counting to discuss industry's most pressing issues
TODAY
Should biosims be the default?
Sandoz has welcomed a Commonwealth consultation into making biosimilars the default when prescribing new medicines
19 May
Global Head issues Aussie warning
Visiting Sanofi leader has warned of the risks to Australia if we fail to speed up access to medicines and vaccines
19 May
Wait time blows out to 3.6 years
Industry's peak body warns that ballooning "bureaucratic delays" is leading some drug makers to abandon the jurisdiction
19 May
Health PR agency snaps up Award
Australian firm well known to pharma has taken home an Asia Pacific gong after speedrunning a brief from the United Nations
18 May
Roundtable to overhaul trial access
'Consortium of the willing' to meet in July to improve the design and delivery of oncology clinical trials making access faster and easier
18 May
Novartis notches a 'first-and-only'
BTK inhibitor approved for a new indication while another company's $50M-plus franchise faces its first rival
18 May Approvals Action
Pharma flags 4500 job cuts
Loss of exclusivity for a blockbuster sees this pharma looking to trim its workforce until its late-stage pipeline matures
15 May
AZ scrambles to shift $17M market
A global decision to discontinue doses of a cancer drug has the local team working hard to ensure patients can maintain treatment
15 May
Ozempic blamed in bizarre stabbing
Claims Ozempic may have made a grandmother who stabbed her daughter-in-law and 10-year-old grandson 'susceptible to violence'
15 May
Industry real estate hub unveiled
ICYMI: See the plans for Sydney's first dedicated commercial life sciences precinct plus the other most popular stories this week
15 May Your Week in 5 Minutes
One-and-done diabetes fix looms
Gene therapy to replace GLP-1 pills and injections is heading into trials in Europe with moves to include Australian participants too
15 May
Heartfelt goodbye from Aussie MD
After 26 years with the same company - six of those leading the ANZ team - this MD has handed over the reins with a fond farewell
14 May
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.